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It is well known that tumour growth rate is important for the outcome of cancer patients (Joseph et al., 1971 : Mattson and Holsti. 1980 : Spratt and Spratt. 1964 . During the last two decades proliferation measurements from tumour material has repeatedly been shown to be of prognostic value in several human cancers (Hall and Levison. 1992) . Theoreti- cally tumour growth rate is determined bv the following factors: the S-phase fraction (SPF). the duration of the Sphase (Ts) and the cell loss factor (CLF) (Steel. 1967) . Of these factors only SPF can be determined from tumour samples without the use of preoperative tumour labelling.
Despite the large literature on the prognostic value of proliferation measurements. the correlation between proliferation assessment from tumour material and actual tumour growth in individual cases has never been investigated. It would be of great value in clinical oncology to be able to estimate growth of metastases from proliferation measurements on primary tumour material. Tumour growth rate varies considerably even between tumours of similar histology (BlomqVist et al.. 1993 (Heiden et al.. 1990 (Heiden et al.. . 1991 .
According to Steel (1967) :
T, =/-Ts SPF from this follows: including breast cancer, gastrointestinal and haematological malignancies (Hall and Levison, 1992 Table II ) an estimate of the cell loss factor in individual cases u-vas made in the present study. The cell loss factor varied from 35°o to 990o with a median of 88%. which is somewhat larger than the previous estimates (Malaise. et al.. 1973 : Steel. 1967 ). The large cell loss factor indicates that cell death is as least as important a factor for clinical tumour growth as cell proliferation.
The estimates of CLF. especiallx in cases with extreme alues. should be x-ieu-ed with extreme caution hou-ever. because thev are calculated on the basis of a number of assumptions. Firstly. there may be differences between the Sphase x-alues in the primarx tumour and its metastases as well as xvariation within the primary tumour itself In a previous study on some of the patients included in this study we found that the growth rate of multiple metastases in the same patient x-as remarkably similar (Blomqvist et al.. 1993 
